BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33421140)

  • 1. Symmetrical drug-related intertriginous and flexural exanthema induced by metronidazole suppository.
    Zhang H; Xie Z
    Contact Dermatitis; 2021 Jun; 84(6):486-488. PubMed ID: 33421140
    [No Abstract]   [Full Text] [Related]  

  • 2. Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) induced by oral metronidazole.
    Şikar Aktürk A; Bayramgürler D; Salman S; Yıldız KD; Odyakmaz Demirsoy E
    Cutan Ocul Toxicol; 2014 Dec; 33(4):337-8. PubMed ID: 24938451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) associated with pristinamycin, secnidazole, and nefopam, with a review of the literature.
    Nespoulous L; Matei I; Charissoux A; Bédane C; Assikar S
    Contact Dermatitis; 2018 Dec; 79(6):378-380. PubMed ID: 30062790
    [No Abstract]   [Full Text] [Related]  

  • 4. Symmetrical drug related intertriginous and flexural exanthema (SDRIFE) induced by fluconazole: An uncommon side effect of a commonly used drug.
    Kumar S; Bhale G; Brar BK
    Dermatol Ther; 2019 Nov; 32(6):e13130. PubMed ID: 31659833
    [No Abstract]   [Full Text] [Related]  

  • 5. Rare case of itraconazole induced SDRIFE (symmetrical drug-related intertriginous and flexural exanthema).
    Koschitzki K; Karrer S; Berneburg M; Niebel D; Drexler K
    J Dtsch Dermatol Ges; 2024 Jun; 22(6):833-836. PubMed ID: 38567643
    [No Abstract]   [Full Text] [Related]  

  • 6. A systematic approach to systemic contact dermatitis and symmetric drug-related intertriginous and flexural exanthema (SDRIFE): a closer look at these conditions and an approach to intertriginous eruptions.
    Winnicki M; Shear NH
    Am J Clin Dermatol; 2011 Jun; 12(3):171-80. PubMed ID: 21469762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Docetaxel-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) confirmed by skin testing.
    Hampel A; Kinaciyan T
    Contact Dermatitis; 2024 May; 90(5):525-527. PubMed ID: 38263696
    [No Abstract]   [Full Text] [Related]  

  • 8. Paracetamol-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) in a psoriasis patient receiving apremilast therapy.
    Megna M; Cinelli E; Napolitano M; Fabbrocini G; Patruno C
    Contact Dermatitis; 2019 Dec; 81(6):451-454. PubMed ID: 31328275
    [No Abstract]   [Full Text] [Related]  

  • 9. Symmetrical drug-related intertriginous and flexural exanthema due to ranitidine.
    Binitha MP; Sasidharanpillai S; John R; Sherjeena PV
    Indian J Pharmacol; 2014; 46(5):551-2. PubMed ID: 25298589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symmetrical drug-related intertriginous and flexural exanthema caused by valacyclovir.
    Daito J; Hanada K; Katoh N; Katoh S; Sakamoto K; Asai J; Takenaka H; Kishimoto S
    Dermatology; 2009; 218(1):60-2. PubMed ID: 18974630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symmetrical drug-related intertriginous and flexural exanthema secondary to topical 5-fluorouracil.
    Powers R; Gordon R; Roberts K; Kovach R
    Cutis; 2012 May; 89(5):225-8. PubMed ID: 22768435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symmetrical drug-related intertriginous and flexural exanthema (baboon syndrome) induced by amoxicillin-clavulanate.
    Dogru M; Ozmen S; Ginis T; Duman H; Bostanci I
    Pediatr Dermatol; 2012; 29(6):770-1. PubMed ID: 22044408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symmetrical drug-related intertriginous and flexural exanthema/baboon syndrome induced by traditional Chinese medicine.
    Liu J; Li LF
    J Cosmet Dermatol; 2022 May; 21(5):2200-2204. PubMed ID: 34333850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three cases of symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) induced by proton-pump inhibitors.
    Spigariolo CB; Barei F; Maronese CA; Barberi F; Cattaneo A; Violetti SA
    Australas J Dermatol; 2022 Nov; 63(4):509-512. PubMed ID: 35877187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SDRIFE (baboon syndrome) due to paracetamol: case report.
    Lugović-Mihić L; Duvančić T; Vučić M; Situm M; Kolić M; Mihić J
    Acta Dermatovenerol Croat; 2013; 21(2):113-7. PubMed ID: 24001419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intertriginous eruption induced by terbinafine: a review of baboon syndrome.
    Janjua SA; Pastar Z; Iftikhar N; Ammad S
    Int J Dermatol; 2017 Jan; 56(1):100-103. PubMed ID: 27153516
    [No Abstract]   [Full Text] [Related]  

  • 17. Oral mucosal involvement and petechial lesions: a SDRIFE case with unusual findings.
    Karadag AS; Ozlu E; Akdeniz N; Uzuncakmak TK; Turkoglu Z; Ozkanli S; Zemheri E
    Cutan Ocul Toxicol; 2016; 35(2):157-9. PubMed ID: 26339719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zoledronic acid-associated symmetrical drug-related intertriginous and flexural exanthema (SDRIFE): report of baboon syndrome in a woman with recurrent metastatic breast cancer after receiving zoledronic acid.
    Cohen PR
    Dermatol Online J; 2015 Aug; 21(8):. PubMed ID: 26437156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levofloxacin-induced symmetric drug-related intertriginous and flexural exanthema.
    Tsai YW; Chung WH; Wang CW; Cheng CY
    Contact Dermatitis; 2022 Jan; 86(1):64-66. PubMed ID: 34553784
    [No Abstract]   [Full Text] [Related]  

  • 20. SDRIFE (baboon syndrome) induced by penicillin.
    Handisurya A; Stingl G; Wöhrl S
    Clin Exp Dermatol; 2009 Apr; 34(3):355-7. PubMed ID: 18699835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.